Share this video  

ELCC 2016 | Biomarkers and lung cancer: Current status

At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Keith Kerr, BSc, MB ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, United Kingdom, discusses biomarker-based selection of therapy and the progress in understanding clinically relevant biomarkers in patients with lung cancer.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter